Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > CXCR3

CXCR3

Brief Information

Name:C-X-C motif chemokine receptor 3
Target Synonym:CKR-L2,G protein-coupled receptor 9,IP-10 receptor,CXCR-3,CXC-R3,CXCR3,C-X-C Motif Chemokine Receptor 3,Interferon-Inducible Protein 10 Receptor,GPR9,C-X-C Chemokine Receptor Type 3,Chemokine Receptor 3,CD183 Antigen,CMKAR3,Chemokine (C-X-C Motif) Receptor 3,Mig Receptor,IP10-R,CD182,CD183,Mig-R,MigR,Receptors, CXCR3
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:2
Lastest Research Phase:Phase 1 Clinical

Product ListCompare or Buy

By Product Status:
By Product Category:
By Species:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
CX3-M52P7 Mouse Mouse CXCR3 Full Length Protein (VLP)
CX3-H52D5 Human Human CXCR3 Protein, Flag,His Tag (Detergent)
CX3-H52D5-structure
CX3-H52P4 Human Human CXCR3 Full Length Protein (VLP)
ACRO Quality

Part of Bioactivity data

CX3-H52P4-SPR
 CXCR3 SPR

Anti-CXCR3 antibody immobilized on CM5 Chip can bind Human CXCR3 Full Length Protein-VLP (Cat. No. CX3-H52P4) with an affinity constant of 60.9 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).

CX3-H52D5-ELISA
 CXCR3 ELISA

Immobilized Human CXCR3 Protein, Flag,His Tag (Cat. No. CX3-H52D5) at 1 μg/mL (100 μL/well) can bind Anti-CXCR3 Antibody, Human IgG1 with a linear range of 0.03-1 ng/mL (QC tested).

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
ACT-777991 ACT-777991 Phase 1 Clinical Idorsia Pharmaceuticals Ltd Inflammation Details
OCU-110 OCU-110; OCU-10-C-110 Phase 1 Clinical Ocugenix Corp Macular Degeneration Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA

Leave a message